A sequential randomized trial has found that both behavioral therapy and the sedative‐hypnotic zolpidem improved daytime symptoms of insomnia, such as mood disturbances and functional impairments. Adding a second stage of therapy resulted in additional improvements in daytime functioning, the investigators found. Study results were published online Dec. 28, 2023, in JAMA Network Open .
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: